Renal Cell Carcinoma With Concurrent Loss of SMARCB1/INI-1... : Applied Immunohistochemistry &...
(or medullary-like) RCC, which is aggressively treated with chemotherapy, primarily platinum-based. In contrast, a distinct set of agents, such as the combination of bevacizumab and erlotinib, is the...
journals.lww.com